Profile data is unavailable for this security.
About the company
KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.
- Revenue in JPY (TTM)5.06bn
- Net income in JPY637.97m
- Incorporated1975
- Employees144.00
- LocationKainos Laboratories Inc2-38-18, HongoBUNKYO-KU 113-0033JapanJPN
- Phone+81 338164123
- Fax+81 338166550
- Websitehttp://www.kainos.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human Metabolome Technologies Inc | 1.34bn | 285.75m | 3.80bn | 57.00 | 13.29 | 1.97 | 10.27 | 2.84 | 48.31 | 48.31 | 226.62 | 326.17 | 0.5643 | 17.82 | 3.80 | 23,500,000.00 | 12.04 | -- | 15.43 | -- | 63.89 | -- | 21.33 | -- | 3.84 | 124.76 | 0.1061 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
Kubota Pharmaceutical Holdings Co Ltd | 39.74m | -1.39bn | 3.83bn | 12.00 | -- | 1.64 | -- | 96.32 | -24.82 | -24.82 | 0.711 | 41.58 | 0.0118 | 0.3815 | 26.89 | 3,312,000.00 | -41.32 | -36.51 | -45.53 | -39.47 | 72.88 | -- | -3,492.38 | -13,528.87 | 8.97 | -- | 0.0555 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
FunPep Co Ltd | 676.00k | -760.40m | 4.03bn | 15.00 | -- | 1.71 | -- | 5,963.56 | -31.52 | -31.52 | 0.028 | 90.56 | 0.0002 | -- | 3.39 | 45,066.67 | -26.86 | -27.10 | -28.42 | -28.75 | -- | -- | -112,484.90 | -815.82 | 17.27 | -1,006.15 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
BrightPath Biotherapeutics Co Ltd | 72.00k | -1.17bn | 4.11bn | 32.00 | -- | 4.19 | -- | 57,147.16 | -18.30 | -18.30 | 0.0011 | 13.84 | 0.00005 | -- | 2.36 | -- | -79.69 | -51.56 | -87.69 | -54.32 | 75.00 | 68.63 | -1,622,336.00 | -22,321.82 | -- | -435.39 | 0.1031 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
Perseus Proteomics Inc | 100.40m | -1.10bn | 4.24bn | 24.00 | -- | 2.77 | -- | 42.25 | -93.74 | -93.74 | 8.52 | 117.15 | 0.0471 | 3.35 | 8.55 | -- | -51.85 | -41.34 | -54.94 | -43.43 | 87.33 | 91.72 | -1,100.04 | -891.26 | 12.77 | -- | -- | -- | 6.58 | -18.31 | -40.34 | -- | 60.30 | -- |
Delta-Fly Pharma Inc | 0.00 | -1.43bn | 4.33bn | 11.00 | -- | 3.51 | -- | -- | -197.24 | -197.24 | 0.00 | 149.78 | 0.00 | -- | -- | -- | -120.07 | -67.70 | -141.25 | -72.02 | -- | -- | -- | -- | -- | -243.15 | -- | -- | -- | -- | -7.57 | -- | -9.04 | -- |
Kringle Pharma Inc | 77.93m | -904.81m | 4.58bn | 13.00 | -- | 1.89 | -- | 58.82 | -159.92 | -159.92 | 13.58 | 356.64 | 0.027 | -- | 2.80 | 5,994,308.00 | -31.29 | -19.00 | -33.20 | -20.23 | -- | -- | -1,161.12 | -156.51 | 12.85 | -- | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
Immuno-Biological Laboratories Co., Ltd. | 816.70m | 186.69m | 4.68bn | 60.00 | 25.04 | 3.70 | -- | 5.73 | 20.05 | 20.05 | 87.69 | 135.86 | 0.535 | 0.9358 | 4.53 | -- | 12.23 | -13.97 | 14.68 | -16.39 | 63.34 | 57.73 | 22.86 | -39.23 | 3.65 | -- | 0.1572 | -- | 2.78 | 0.8924 | 164.44 | -- | -- | -- |
Renascience Inc | 194.17m | -258.34m | 4.68bn | 3.00 | -- | 2.91 | -- | 24.09 | -20.32 | -20.32 | 15.27 | 126.40 | 0.089 | -- | -- | -- | -11.84 | -- | -12.49 | -- | 85.31 | -- | -133.05 | -- | -- | -- | 0.1814 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
Kidswell Bio Corp | 2.43bn | -1.42bn | 4.92bn | 41.00 | -- | 5.85 | -- | 2.03 | -40.81 | -40.81 | 68.79 | 21.35 | 0.5415 | 1.84 | 2.47 | -- | -31.67 | -57.41 | -51.25 | -81.13 | 42.75 | 55.20 | -58.49 | -123.52 | 1.70 | -28.91 | 0.7559 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
KAINOS Laboratories, Inc. | 5.06bn | 637.97m | 5.18bn | 144.00 | 7.45 | 0.7643 | 6.84 | 1.02 | 152.41 | 152.41 | 1,206.78 | 1,486.43 | 0.6053 | 3.08 | 4.55 | -- | 7.64 | 6.92 | 9.96 | 9.26 | 50.46 | 51.84 | 12.62 | 10.80 | 2.43 | -- | 0.1221 | 18.46 | 2.71 | 1.60 | 12.28 | 10.57 | -9.83 | 16.36 |
OncoTherapy Science, Inc. | 610.12m | -1.29bn | 5.27bn | 60.00 | -- | 13.54 | -- | 8.63 | -6.09 | -6.09 | 2.87 | 1.62 | 0.513 | 9.08 | 7.69 | -- | -108.31 | -55.67 | -182.73 | -63.82 | -29.13 | -1.49 | -211.13 | -247.47 | 2.07 | -189.93 | 0.232 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
Solasia Pharma KK | 408.00m | -1.18bn | 5.42bn | 24.00 | -- | 2.80 | -- | 13.28 | -6.96 | -6.96 | 2.40 | 10.01 | 0.1432 | 2.01 | 3.06 | 17,000,000.00 | -41.50 | -48.57 | -53.67 | -58.83 | 51.23 | 71.01 | -289.71 | -300.89 | 1.68 | -400.00 | 0.2327 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
Noile-Immune Biotech Inc | 311.30m | -975.80m | 5.67bn | 28.00 | -- | 1.06 | -- | 18.22 | -22.56 | -22.56 | 7.19 | 123.55 | 0.0658 | 0.139 | 5.07 | 11,118,000.00 | -20.62 | -- | -21.29 | -- | 99.55 | -- | -313.45 | -- | 52.74 | -805.65 | 0.00 | -- | -49.37 | -- | -192.28 | -- | -- | -- |
Cyfuse Biomedical KK | 64.79m | -645.40m | 6.05bn | 21.00 | -- | 1.97 | -- | 93.37 | -82.27 | -82.27 | 8.26 | 378.39 | 0.0153 | 0.5202 | 13.80 | 3,085,095.00 | -15.19 | -- | -17.68 | -- | 61.81 | -- | -996.19 | -- | 6.39 | -81.61 | 0.2126 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
DNA Chip Research Inc | 490.46m | -248.29m | 6.17bn | 36.00 | -- | 8.42 | -- | 12.58 | -39.09 | -39.09 | 77.17 | 108.27 | 0.5292 | 9.84 | 3.11 | -- | -26.79 | -23.49 | -32.60 | -26.70 | 13.53 | 14.28 | -50.62 | -54.10 | 2.92 | -2,206.97 | -- | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
Data as of May 31 2024. Currency figures normalised to Kainos Laboratories Inc's reporting currency: Japanese Yen JPY
Holder | Shares | % Held |
---|---|---|
Lemanik Invest SAas of 30 Apr 2024 | 38.00k | 0.83% |
Simplex Asset Management Co., Ltd.as of 09 May 2024 | 200.00 | 0.00% |
Data from 30 Apr 2024 - 23 May 2024Source: FactSet Research Systems Inc.